Infusive Technologies
2004
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of proprietary and patented multi-chamber, sequential, dose syringe technology. The company develops syringe technology developed under its product name "ChaSyr" which allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple syringes with just one.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
- 620 South Main Street
- Bountiful, UT 84010
- United States
Infusive Technologies Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Infusive Technologies‘s full profile, request access.
Request full access to PitchBookInfusive Technologies Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Gale Thorne Jr. | President & Chief Operating Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »